BackgroundParkinsons disease (PD) and schizophrenia (SZ), while clinically distinct, exhibit overlapping symptoms and neurobiological features. Emerging genetic evidence suggests a shared heritable component between the two disorders. In this study, we aim to identify novel genetic loci common to both PD and SZ and to further investigate the convergent molecular mechanisms that may underlie their shared pathophysiology.
MethodsWe analyzed large-scale genome-wide association studies (GWAS) on SZ (55,193 cases and 74,132 controls) and PD (56,306 cases and 1,417,791 controls) using a proxy-phenotype method combined with a Bayesian statistical approach to evaluate overlap in common genetic variants and enhance statistical power for genetic discovery. To elucidate the biological mechanisms underlying newly identified shared genetic loci associated with PD and SZ, we leveraged single-cell RNA sequencing (scRNA-seq) data from induced pluripotent stem cell (iPSC)-derived dopaminergic neurons generated by the FOUNDIN-PD consortium (416,216 high-quality single-cells from PD patients). We performed differential gene expression analysis, and gene ontology (GO) enrichment analysis to systematically investigate the functional relevance of one shared loci in a disease-relevant cellular context. The polygenic risk score (PRS) model was constructed by stratifying overlapping SNPs based on effect directions to predict PD clinical outcomes in the Tuebingen Parkinson cohort (TUEPAC). MAGMA gene-set enrichment analysis was used to identify the cell types enriched for each SNP set.
Sun, W. et al. · CC-BY 4.0